Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Consolidated Research: 2018 Summary Expectations for CACI International, SELECT EGY SVCS, Internap, Sotheby's, Verint, and Corbus Pharmaceuticals — Fundamental Analysis, Key Performance Indications

CACI, WTTR, VRNT, CRBP

NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CACI International, Inc. (NYSE:CACI), SELECT EGY SVCS (NYSE:WTTR), Internap Corporation (NASDAQ:INAP), Sotheby's (NYSE:BID), Verint Systems Inc. (NASDAQ:VRNT), and Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CACI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CACI
WTTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=WTTR
INAP DOWNLOAD: http://Fundamental-Markets.com/register/?so=INAP
BID DOWNLOAD: http://Fundamental-Markets.com/register/?so=BID
VRNT DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRNT
CRBP DOWNLOAD: http://Fundamental-Markets.com/register/?so=CRBP

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine CACI International, Inc. (NYSE:CACI), SELECT EGY SVCS (NYSE:WTTR), Internap Corporation (NASDAQ:INAP), Sotheby's (NYSE:BID), Verint Systems Inc. (NASDAQ:VRNT), and Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed July 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CACI INTERNATIONAL, INC. (CACI) REPORT OVERVIEW

CACI International's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, CACI International reported revenue of $1,124.10MM vs $1,086.42MM (up 3.47%) and basic earnings per share $2.62 vs $1.65 (up 58.79%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, CACI International reported revenue of $4,354.62MM vs $3,744.05MM (up 16.31%) and basic earnings per share $6.71 vs $5.89 (up 13.92%). CACI International is expected to report earnings on August 15th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.76. The estimated EPS forecast for the next fiscal year is $9.20 and is expected to report on August 15th, 2018.

To read the full CACI International, Inc. (CACI) report, download it here: http://Fundamental-Markets.com/register/?so=CACI

-----------------------------------------

SELECT EGY SVCS (WTTR) REPORT OVERVIEW

SELECT EGY SVCS's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, SELECT EGY SVCS reported revenue of $376.40MM vs $99.93MM (up 276.68%) and basic earnings per share $0.10 vs -$0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, SELECT EGY SVCS reported revenue of $692.49MM vs $302.40MM (up 129.00%) and basic earnings per share -$0.24 vs -$0.02. SELECT EGY SVCS is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.05. The estimated EPS forecast for the next fiscal year is $1.47 and is expected to report on March 6th, 2019.

To read the full SELECT EGY SVCS (WTTR) report, download it here: http://Fundamental-Markets.com/register/?so=WTTR

-----------------------------------------

INTERNAP CORPORATION (INAP) REPORT OVERVIEW

Internap's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Internap reported revenue of $74.20MM vs $72.13MM (up 2.87%) and basic earnings per share -$0.70 vs -$0.50. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Internap reported revenue of $280.72MM vs $298.30MM (down 5.89%) and basic earnings per share -$2.39 vs -$9.54. Internap is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.32. The estimated EPS forecast for the next fiscal year is -$1.70 and is expected to report on March 14th, 2019.

To read the full Internap Corporation (INAP) report, download it here: http://Fundamental-Markets.com/register/?so=INAP

-----------------------------------------

SOTHEBY'S (BID) REPORT OVERVIEW

Sotheby's' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Sotheby's reported revenue of $195.80MM vs $199.31MM (down 1.76%) and basic earnings per share -$0.12 vs -$0.21. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sotheby's reported revenue of $989.39MM vs $805.38MM (up 22.85%) and basic earnings per share $2.22 vs $1.28 (up 73.44%). Sotheby's is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.43. The estimated EPS forecast for the next fiscal year is $3.13 and is expected to report on March 7th, 2019.

To read the full Sotheby's (BID) report, download it here: http://Fundamental-Markets.com/register/?so=BID

-----------------------------------------

VERINT SYSTEMS INC. (VRNT) REPORT OVERVIEW

Verint's Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Verint reported revenue of $289.21MM vs $261.00MM (up 10.81%) and basic earnings per share -$0.03 vs -$0.32. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Verint reported revenue of $1,135.23MM vs $1,062.11MM (up 6.88%) and basic earnings per share -$0.10 vs -$0.47. Verint is expected to report earnings on September 5th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.35. The estimated EPS forecast for the next fiscal year is $2.57 and is expected to report on March 27th, 2019.

To read the full Verint Systems Inc. (VRNT) report, download it here: http://Fundamental-Markets.com/register/?so=VRNT

-----------------------------------------

CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) REPORT OVERVIEW

Corbus Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Corbus Pharmaceuticals reported revenue of $0.95MM vs $1.29MM (down 26.54%) and basic earnings per share -$0.21 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Corbus Pharmaceuticals reported revenue of $2.44MM vs $1.91MM (up 27.67%) and basic earnings per share -$0.65 vs -$0.49. Corbus Pharmaceuticals is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.15. The estimated EPS forecast for the next fiscal year is -$0.92 and is expected to report on March 11th, 2019.

To read the full Corbus Pharmaceuticals Holdings, Inc. (CRBP) report, download it here: http://Fundamental-Markets.com/register/?so=CRBP

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com 

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today